Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.37 $15.43 Thursday, 9th May 2024 URGN stock ended at $12.97. This is 2.26% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 4.81% from a day low at $12.60 to a day high of $13.21.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Oct 18, 2017 $29.21 $29.71 $27.78 $27.93 35 048
Oct 17, 2017 $28.88 $29.29 $28.75 $28.86 11 920
Oct 16, 2017 $29.46 $29.92 $28.75 $28.94 17 636
Oct 13, 2017 $29.81 $29.94 $29.00 $29.00 17 300
Oct 12, 2017 $30.63 $30.74 $29.30 $29.87 11 196
Oct 11, 2017 $30.10 $30.94 $29.70 $30.75 15 618
Oct 10, 2017 $30.35 $30.35 $29.50 $30.19 14 536
Oct 09, 2017 $29.13 $31.95 $29.13 $29.80 52 109
Oct 06, 2017 $30.30 $30.68 $28.94 $29.36 39 729
Oct 05, 2017 $30.68 $32.24 $30.41 $30.46 12 629
Oct 04, 2017 $32.16 $32.70 $30.21 $30.88 34 583
Oct 03, 2017 $32.67 $32.95 $31.57 $31.97 27 928
Oct 02, 2017 $31.29 $33.17 $31.29 $32.17 16 322
Sep 29, 2017 $32.72 $33.70 $31.52 $31.52 40 653
Sep 28, 2017 $31.01 $32.93 $30.51 $32.43 36 819
Sep 27, 2017 $31.20 $31.67 $30.31 $30.70 21 620
Sep 26, 2017 $31.50 $32.49 $30.20 $31.18 38 472
Sep 25, 2017 $29.96 $31.93 $29.96 $31.05 24 785
Sep 22, 2017 $29.31 $30.98 $29.31 $30.49 26 409
Sep 21, 2017 $29.81 $29.81 $28.19 $29.51 34 577
Sep 20, 2017 $32.25 $32.25 $29.18 $30.06 95 862
Sep 19, 2017 $32.30 $32.30 $30.14 $31.92 102 040
Sep 18, 2017 $33.23 $33.23 $31.70 $32.13 53 067
Sep 15, 2017 $33.29 $33.77 $31.77 $32.69 62 285
Sep 14, 2017 $31.37 $32.95 $30.01 $32.72 97 976
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT